Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Congenital hereditary facial paralysis-variable hearing loss syndrome is an extremely rare autosomal recessive disorder characterized by bilateral facial palsy with masked facies, sensorineural hearing loss, dysmorphic features (midfacial retrusion, low-set ears), and strabismus.
Biomarker and diagnostic research for congenital hereditary facial paralysis-variable hearing loss syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for congenital hereditary facial paralysis-variable hearing loss syndrome.
3 publications have been identified in PubMed for congenital hereditary facial paralysis-variable hearing loss syndrome. Research spans Diagnostic / Biomarker (33%), Review / Meta-Analysis (33%), and Basic Science / Preclinical (33%).
Almpani K (2026). [PMID: 40611650](https://pubmed.ncbi.nlm.nih.gov/40611650/). *Cleft Palate Craniofac J*. [Basic Science / Preclinical]
Webb BD (2025). [PMID: 40662098](https://pubmed.ncbi.nlm.nih.gov/40662098/). *Genet Med Open*. [Review / Meta-Analysis]
Lee NK (2024). [PMID: 39062005](https://pubmed.ncbi.nlm.nih.gov/39062005/). *Biomedicines*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 12:01 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center